Are you Dr. Olanow?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 31 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5 E 98th St
7th Floor
New York, NY 10029Phone+1 212-241-7076Fax+1 212-860-4952- Is this information wrong?
Summary
- Dr. C. Olanow, MD is a neurologist in New York, New York. He is currently licensed to practice medicine in New York. He is affiliated with The Mount Sinai Hospital and is a Professor of Neurology at Mount Sinai School of Medicine.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1968 - 1971
University of HawaiiInternship, Internal Medicine, 1966 - 1967
University of Toronto Faculty of MedicineClass of 1965
Certifications & Licensure
NY State Medical License 1994 - 2020
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- New York Magazine: Top Doctors Castle Connolly, 2002-2008
- Join now to see all
Clinical Trials
- Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease Start of enrollment: 1996 Jan 01
Publications & Presentations
PubMed
- 1 citationsSafety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised,...Alberto J Espay, Fabrizio Stocchi, Rajesh Pahwa, Alberto Albanese, Aaron Ellenbogen, Joaquim J Ferreira, Nir Giladi, Tanya Gurevich, Sharon Hassin-Baer, Jorge Hernande...> ;The Lancet. Neurology. 2024 May 1
- A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.Milton H Werner, C Warren Olanow, Andrew McGarry, Christopher Meyer, Sydney Kruger, Carl Klint, Jacqueline Pellecchia, Shannon Walaker, Larry Ereshefsky, Lawrence Blob...> ;Journal of Parkinson's Disease. 2024 Jan 1
- 2 citationsSafety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.McGarry, A., Rosanbalm, S., Leinonen, M., Olanow, C., To, D., Bell, A., Lee, D., Chang, J., Dubow, J., Dhall, R., Burdick, D., Parashos, S., Feuerstein, J., Quinn, J.,...> ;The Lancet. Neurology. 2024 Jan 1
- Join now to see all
Hospital Affiliations
The Mount Sinai HospitalNew York, New York
